IV DHE

DRUG2 trials

Sponsors

Allergan

Conditions

HealthyHealthy Subjects

Phase 1

Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers

CompletedNCT01199965

AllerganHealthy Subjects

Start: 2010-01-31End: 2010-04-30Updated: 2014-01-09

Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole

CompletedNCT01468558

AllerganHealthy

Start: 2010-07-31End: 2010-08-31Updated: 2014-01-09